SEATTLE, March 26, 2025 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective,” the “Company,” “we,” “us,” and “our”) (NYSE AMERICAN ...

Triple-I reported more than 22,000 earned media mentions in 2024, with thought leadership addressing natural disasters, ...

SEATTLE, March 26, 2025 (GLOBE NEWSWIRE) -- Perspective Therapeutics ... presentation by the investigator was during the 37 th Annual Congress of the European Association of Nuclear Medicine ...

Perspective is entitled to certain cash royalties on net ... press release are described under the heading "Risk Factors" in the Company's most recent Annual Report on Form 10-K and Quarterly Report ...